| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20,900 | 30 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 17:37 |
| ATHA | Athira Pharma, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 18:54 |
| ATHA | Athira Pharma, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 22 May 2023, 17:58 |
| ATHA | Athira Pharma, Inc. | 20 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 17:42 |
| ATHA | Athira Pharma, Inc. | 15 Jun 2021 | 2 | $0 | 4 | Director | 16 Jun 2021, 18:50 |
| ATHA | Athira Pharma, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:25 |